CYP1A1 and neoplasm: Our objective was to define a possible potential role of gefitinib metabolism in early evaluation of tumor response to gefitinib, to analyze conditions or factors that can alter tumor gefitinib metabolism and to test the effect of CYP1A1 inhibition on gefitinib efficacy.